12 Health Care Stocks Moving In Thursday's Intraday Session

 

Gainers

  • Salarius Pharmaceuticals SLRX stock moved upwards by 31.4% to $0.49 during Thursday's regular session. The current volume of 2.4 million shares is 738.3% of Salarius Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $22.2 million. As per the news, the Q4 earnings report came out today.
  • SenesTech SNES stock moved upwards by 26.23% to $1.01. Trading volume for SenesTech's stock is 2.3 million as of 12:30 EST. This is 2423.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.3 million.
  • Natera NTRA shares increased by 24.27% to $45.73. Natera's stock is trading at a volume of 12.0 million shares as of 12:30 EST. This is 702.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.3 billion.
  • Yield10 Bioscience YTEN stock increased by 19.43% to $5.53. As of 12:30 EST, this security is trading at a volume of 1.8 million shares, making up 1676.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $26.9 million. As per the news, the Q4 earnings report came out yesterday.
  • Kala Pharmaceuticals KALA shares moved upwards by 18.14% to $1.33. Trading volume for this security as of 12:30 EST is 8.5 million, which is 631.8% of its average full-day volume over the last 100 days. The company's market cap stands at $96.5 million.
  • AquaBounty Technologies AQB shares moved upwards by 17.14% to $1.64. The current volume of 2.3 million shares is 215.7% of AquaBounty Technologies's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $116.4 million. As per the news, the Q4 earnings report came out today.

Losers

  • Sunshine Biopharma SBFM shares fell 32.1% to $2.58 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 2.6 million, which is 109.7% of its average full-day volume over the last 100 days. The company's market cap stands at $11.5 million.
  • TherapeuticsMD TXMD shares decreased by 30.63% to $0.28. As of 12:30 EST, TherapeuticsMD's stock is trading at a volume of 13.9 million, which is 189.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $117.9 million. As per the press release, Q4 earnings came out today.
  • Revelation Biosciences REVB shares declined by 23.53% to $1.3. The current volume of 2.3 million shares is 114.2% of Revelation Biosciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $18.5 million.
  • NexImmune NEXI shares declined by 21.31% to $1.81. As of 12:30 EST, this security is trading at a volume of 408.8K shares, making up 419.5% of its average full-day volume over the last 100 days. The company's market cap stands at $41.1 million. As per the press release, Q4 earnings came out yesterday.
  • TC BioPharm (Holdings) TCBP stock fell 21.02% to $1.09. Trading volume for this security as of 12:30 EST is 687.1K, which is 28.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $30.5 million.
  • Acorda Therapeutics ACOR stock fell 19.19% to $1.82. Acorda Therapeutics's stock is trading at a volume of 94.3K shares as of 12:30 EST. This is 108.8% of its average full-day volume over the last 100 days. The company's market cap stands at $20.3 million. As per the news, the Q4 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Intraday UpdateMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!